Booster Dose of J&J COVID-19 Vaccine May Increase Immunity

TUESDAY, Sept. 21, 2021 (HealthDay News) -- Getting a second dose of the Johnson & Johnson COVID-19 vaccine substantially increased its protection, the company announced Tuesday.
According to the results of a new clinical trial, two doses of the vaccine boost immunity to 94 percent from the 74 percent offered by a single dose, the company said in a statement.
"Our single-shot vaccine generates strong immune responses and long-lasting immune memory. And, when a booster of the Johnson & Johnson COVID-19 vaccine is given, the strength of protection against COVID-19 further increases," Mathai Mammen, M.D., Ph.D., global head of Janssen Research and Development at Johnson & Johnson, said in the statement.
Two shots are also 100 percent effective against a severe bout of disease, the company claimed. But that estimate is not certain, The New York Times reported.
The new data have been submitted to the U.S. Food and Drug Administration. Since the single-dose Johnson & Johnson vaccine was approved in February, nearly 15 million Americans have gotten it, The Times said.
Related Posts
Un estudio compara dos diuréticos comunes que se usan para la insuficiencia cardiaca
MARTES, 8 de noviembre de 2022 (HealthDay News) -- Los pacientes con...
Una buena licencia de maternidad mejora mucho la salud mental de mamá
JUEVES, 5 de enero de 2023 (HealthDay News) -- Unas políticas generosas de...
Hacer ejercicio poco después de una cirugía plástica para los senos es seguro y saludable
MARTES, 28 de diciembre de 2021 (HealthDay News) -- Aunque algunos cirujanos...
Prostatitis: What It Is, Symptoms, Causes & Treatment
WEDNESDAY, May 31, 2023 (HealthDay News) -- When most men think about their...